TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
MKSI

MKS Instruments Inc

Technology · Scientific & Technical Instruments

256.90$ +1.9% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Cash Flow

MKS Instruments Inc (MKSI) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at 645 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow MKSI
Line item 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
23 17 34 20 14 -0.2 66 64 78 119 90 7.4 163 156 137 76 102 138 180 355 414 245 513 640 529 319 528 645
6.2 6.2 11 27 29 28 28 26 31 31 24 19 14 13 14 17 21 22 66 83 80 110 99 104 216 397 348 344
-3.4 13 13 15 6.6 5.7 11 13 14 11 13 25 24 27 49 30 37 45 54 48 55
8.6 9.6 1.4 6.5 27 29 31 32 29 26 22 -27 34 68 50 53 29
11 -9.5 -20 31 9.6 -13 -16 1.5 -50 -5.9 21 -33 -20 -16 44 -9.3 -63 -32 -22 -50 -98 -88 11 -72 -157 -99 4.0 75
3.1 5.5 11 15 7.9 6.3 18 10 11 15 13 4.2 16 16 18 12 13 12 19 31 63 64 85 87 164 87 118 148
-2.1 -33 -20 -18 -52 -21 -44 20 -114 -61 -74 -9.6 -106 -6.1 -118 -37 -25 -167 -727 23 73 -947 -202 -205 -4,552 -84 -117 -145
6.2 40 1.4 0.0 31 33 34 35 36 36 38 42 44 44 48 52 59 59 59
-101 -116 0.0 -2.0 -12 -2.9 -21 -13 -1.5 0.0 -75 0.0 0.0 0.0 0.0 -45
-14 1.9 -6.5 -0.8 598 598 598 -229 -49 531 -57 -14 4,026 -187 -266 -451
-12 41 -5.0 -4.3 5.5 5.3 40 0.9 30 -59 -115 -5.6 -5.0 2.4 -47 -37 -53 -47 560 -280 -178 476 -122 -65 3,971 -259 -549 -562
8.7 25 9.0 -2.2 -32 -14 64 82 -5.4 8.8 -105 -8.3 51 150 -25 1.3 17 -78 6.3 100 310 -230 194 358 -57 -34 -161 -39
20 12 23 5.5 5.9 -6.5 48 54 68 104 76 3.2 148 140 119 64 89 126 161 324 351 181 428 553 365 232 410 497

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?